| Journal Profile | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Journal Title | Chinese Journal of Cancer (According to the latest JCR data, this journal is not indexed in the JCR.) | ||||||||||||||||
| Journal Title Abbreviations | CHIN J CANCER | ||||||||||||||||
| ISSN | 1000-467X | ||||||||||||||||
| h-index | 42 | ||||||||||||||||
| CiteScore |
| ||||||||||||||||
| Self-Citation Ratio (2020-2021) | N/A | ||||||||||||||||
| 期刊简介 | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. | ||||||||||||||||
| Official Website | http://cjcjournal.biomedcentral.com/ | ||||||||||||||||
| Online Manuscript Submission | https://www.editorialmanager.com/chjc/default.aspx | ||||||||||||||||
| Open Access | Yes | ||||||||||||||||
| Publisher | |||||||||||||||||
| Subject Area | ONCOLOGY | ||||||||||||||||
| Country/Area of Publication | United Kingdom | ||||||||||||||||
| Publication Frequency | |||||||||||||||||
| Year Publication Started | 0 | ||||||||||||||||
| Annual Article Volume | 0 | ||||||||||||||||
| Gold OA文章占比 | |||||||||||||||||
| OA期刊相关信息 | |||||||||||||||||
| WOS期刊SCI分区 | |||||||||||||||||
| Indexing (SCI or SCIE) | |||||||||||||||||
| Link to PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1000-467X%5BISSN%5D | ||||||||||||||||
| Average Duration of Peer Review * | Authorized Data from Publisher: Data from Authors: 12 Weeks | ||||||||||||||||
| Competitiveness * | Data from Authors: | ||||||||||||||||
| Useful Links |
| ||||||||||||||||
| *All review process metrics, such as acceptance rate and review speed, are limited to our user-submitted manuscripts. As such they may not reflect the journals' exact competitiveness or speed. | |||||||||||||||||
|
|
| |
| First Previous 1 Next Last (To Page | |
| Reviews on Chinese Journal of Cancer: | Write a review |
| Author: lry Subject Area: Medical Science Duration of Peer Review: 1.0 month(s) Result: Accepted after revision Write a review |
Reviewed 2017-09-26 12:32:51 The quality of contributing manuscripts has been greatly improved after the journal partnered with BioMed Central Publishing Group. The IF is gradually increasing, and it is expected to exceed 5 next year. It is the number one oncology journal in China. Papers must have a certain degree of novelty and of certain quality to be considered here, but this journal should be easier than other IF 4-5 journals to get accepted.  (1) Thank | lry  |
| Author: drofcancer@yahoo.com Subject Area: Medical Science Duration of Peer Review: 1.0 month(s) Result: Accepted after revision Write a review |
Reviewed 2021-01-05 04:02:16 Meta-Analysis Of Positive Mutation EGFR For Erlotinib, Gefitinib Or Icotinib Plus Chinese Medicine Versus Erlotinib, Gefitinib Or Icotinib Alone In Patients With Non Small Cell Lung Cancer, A Regional Study East China (0) Thank | drofcancer@yahoo.com |
| Author: drofcancer@yahoo.com Subject Area: Medical Science Duration of Peer Review: 1.0 month(s) Result: Accepted after revision Write a review |
Reviewed 2021-01-05 04:02:15 Meta-Analysis Of Positive Mutation EGFR For Erlotinib, Gefitinib Or Icotinib Plus Chinese Medicine Versus Erlotinib, Gefitinib Or Icotinib Alone In Patients With Non Small Cell Lung Cancer, A Regional Study East China (0) Thank | drofcancer@yahoo.com |
| Author: drofcancer@yahoo.com Subject Area: Medical Science Duration of Peer Review: 1.0 month(s) Result: Accepted after revision Write a review |
Reviewed 2021-01-05 04:01:24 Meta-Analysis Of Positive Mutation EGFR For Erlotinib, Gefitinib Or Icotinib Plus Chinese Medicine Versus Erlotinib, Gefitinib Or Icotinib Alone In Patients With Non Small Cell Lung Cancer, A Regional Study East China (0) Thank | drofcancer@yahoo.com |
| First Previous 1 Next Last (To Page | |